Trexquant Investment’s Immunocore IMCR Stock Holding History

Trexquant Investment’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Buy	72,846 +52,161	+252%	+$1.54M	0.01%	1134
2026 Q1	$624K	Buy	+20,685	New	+$669K	﹤0.01%	1398
2025 Q4	–	Sell	-100,580	Closed	-$3.65M	–	1746
2025 Q3	$3.65M	Buy	100,580 +81,291	+421%	+$2.76M	0.04%	669
2025 Q2	$605K	Buy	+19,289	New	+$599K	0.01%	1212
2024 Q1	–	Sell	-28,545	Closed	-$1.95M	–	1589
2023 Q4	$1.95M	Buy	28,545 +1,746	+7%	+$90.8K	0.04%	558
2023 Q3	$1.39M	Buy	26,799 +18,768	+234%	+$1.11M	0.03%	625
2023 Q2	$482K	Sell	8,031 -29,213	-78%	-$1.67M	0.01%	1020
2023 Q1	$1.84M	Buy	37,244 +20,992	+129%	+$1.18M	0.05%	488
2022 Q4	$928K	Buy	+16,252	New	+$915K	0.03%	673

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Trexquant Investment's IMCR Position: Q2 2026 in Review

Trexquant Investment increased its Immunocore (IMCR) stake by 252% in Q2 2026, buying an estimated $1.54M and bringing the position to 72,846 shares worth $2.31M. The position accounts for 0.01% of the portfolio, ranked #1134.

Trexquant Investment first reported a position in IMCR in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.65M in Q3 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Trexquant Investment held 72,846 shares of Immunocore worth $2.31M as of Q2 2026.
Trexquant Investment bought 52,161 Immunocore shares in Q2 2026, an estimated $1.54M.
Immunocore made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1134 holding.
Trexquant Investment first reported a position in Immunocore in Q4 2022 and has held it in 9 quarters since.
Trexquant Investment's Immunocore position peaked at $3.65M in Q3 2025.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.